These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2509889)

  • 1. Pap smear screening--Behavioral Risk Factor Surveillance System, 1988.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1989 Nov; 38(45):777-9. PubMed ID: 2509889
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer screening behaviors among U.S. women: breast cancer, 1987-1989, and cervical cancer, 1988-1989.
    Ackermann SP; Brackbill RM; Bewerse BA; Cheal NE; Sanderson LM
    MMWR CDC Surveill Summ; 1992 Apr; 41(2):17-25. PubMed ID: 1594013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case management intervention in cervical cancer prevention: the Boston REACH coalition women's health demonstration project.
    Clark CR; Baril N; Hall A; Kunicki M; Johnson N; Soukup J; Lipsitz S; Bigby J
    Prog Community Health Partnersh; 2011; 5(3):235-47. PubMed ID: 22080772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of papanicolaou smears by South Asian women living in the United States.
    Chaudhry S; Fink A; Gelberg L; Brook R
    J Gen Intern Med; 2003 May; 18(5):377-84. PubMed ID: 12795737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papanicolaou testing among women in the southern United States.
    Peterson NB; Murff HJ; Cui Y; Hargreaves M; Fowke JH
    J Womens Health (Larchmt); 2008; 17(6):939-46. PubMed ID: 18582173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
    Subramaniam A; Fauci JM; Schneider KE; Whitworth JM; Erickson BK; Kim K; Huh WK
    J Low Genit Tract Dis; 2011 Apr; 15(2):110-3. PubMed ID: 21263352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Papanicolaou smear screening rate of women with HIV infection: a nationwide population-based study in Taiwan, 2000-2010.
    Chen YC; Liu HY; Li CY; Lee NY; Ko WC; Chou CY; Hsieh TH; Ko NY
    J Womens Health (Larchmt); 2013 Dec; 22(12):1016-22. PubMed ID: 23992102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991-1998 (United States).
    Benard VB; Lee NC; Piper M; Richardson L
    Cancer Causes Control; 2001 Jan; 12(1):61-8. PubMed ID: 11227926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer screening among HIV-infected women in a health department setting.
    Logan JL; Khambaty MQ; D'Souza KM; Menezes LJ
    AIDS Patient Care STDS; 2010 Aug; 24(8):471-5. PubMed ID: 20653483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of a first-time atypical Papanicolaou smear in a young, high-risk African-American and Latino-American population.
    Parham GP; Shaver M; Brown P; Zumwalt T; Salem F; Savage EW
    J Natl Med Assoc; 1994 Apr; 86(4):273-7. PubMed ID: 7794301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papanicolaou test use among reproductive-age women at high risk for cervical cancer: analyses of the 1995 National Survey of Family Growth.
    Hewitt M; Devesa S; Breen N
    Am J Public Health; 2002 Apr; 92(4):666-9. PubMed ID: 11919069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceived discrimination is associated with reduced breast and cervical cancer screening: the Study of Women's Health Across the Nation (SWAN).
    Jacobs EA; Rathouz PJ; Karavolos K; Everson-Rose SA; Janssen I; Kravitz HM; Lewis TT; Powell LH
    J Womens Health (Larchmt); 2014 Feb; 23(2):138-45. PubMed ID: 24261647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The frequency of Pap smear screening in the United States.
    Sirovich BE; Welch HG
    J Gen Intern Med; 2004 Mar; 19(3):243-50. PubMed ID: 15009779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personal influencing factors associated with pap smear testing and cervical cancer.
    Ackerson K; Pohl J; Low LK
    Policy Polit Nurs Pract; 2008 Feb; 9(1):50-60. PubMed ID: 18492942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pap smear screening and cervical pathology in an American Indian population.
    Skubi D
    J Nurse Midwifery; 1988; 33(5):203-7. PubMed ID: 3221264
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of Pap smear screening results between Akha hill tribe and urban women in Chiang Rai province, Thailand.
    Kritpetcharat O; Wutichouy W; Sirijaichingkul S; Kritpetcharat P
    Asian Pac J Cancer Prev; 2012; 13(11):5501-4. PubMed ID: 23317207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting intentions to obtain a Pap smear among African American and Latina women: testing the theory of planned behavior.
    Jennings-Dozier K
    Nurs Res; 1999; 48(4):198-205. PubMed ID: 10414682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problems and progress with Pap smear screening reviewed.
    Volkers N
    J Natl Cancer Inst; 1992 Nov; 84(22):1694-5. PubMed ID: 1433354
    [No Abstract]   [Full Text] [Related]  

  • 19. Determinants factors to Pap smear screening among married women in a city of South Iran: applying the BASNEF model.
    Momeni R; Hosseini Z; Aghamolaei T; Ghanbarnejad A
    BMC Womens Health; 2020 Oct; 20(1):237. PubMed ID: 33081778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cancer screening: who is not screened and why?
    Harlan LC; Bernstein AB; Kessler LG
    Am J Public Health; 1991 Jul; 81(7):885-90. PubMed ID: 2053665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.